Professor Jesús María Hernández of the University of  Salamanca will coordinate through the IBSAL Institute one of the largest European projects ever attained in Spain.

Finding more effective treatments for haematological tumours is the final goal of  HARMONY, a European project approved by the Initiative for Innovative Medicines (IMI2). The project will be led by two Spanish haematologists and coordinated by the Institute for Biomedical Research of Salamanca (IBSAL). Using Big Data, the researchers will attempt to draw a European map of this type of tumour, which is the fifth most frequent and the third most fatal.

As published in the media:

Posted by Juan M. Corchado

Catedrático en el Área de Ciencias de la Computación e Inteligencia Artificial de la Universidad de Salamanca. Director del Grupo de Investigación BISITE // Full Professor in Area of Computer Science and Artificial Intelligence at University of Salamanca. Director of the BISITE Research Group

Thanks for your comment

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.